 |
GSK defends drug against Senate reportGlaxoSmithKline, in response to a staff report of the US Senate, said that the report draws conclusions on the safety of its diabetes drug Avandia on analyses not consistent with the rigorous scientific evidence supporting the safety of the drug. More… |
Monday 23 December 2024
